US Incidence of Late-Preterm Steroid Use and Associated Neonatal Respiratory Morbidity After Publication of the Antenatal Late Preterm Steroids Trial, 2015-2017

IMPORTANCE: The Antenatal Late Preterm Steroids (ALPS) trial demonstrated a 20% reduction in the risk of respiratory complications in neonates at risk for a late-preterm birth who were exposed to antenatal corticosteroids compared with those who were not. OBJECTIVE: To assess whether new evidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Clapp, Mark A., Melamed, Alexander, Freret, Taylor S., James, Kaitlyn E., Gyamfi-Bannerman, Cynthia, Kaimal, Anjali J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118048/
https://www.ncbi.nlm.nih.gov/pubmed/35583868
http://dx.doi.org/10.1001/jamanetworkopen.2022.12702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118048/
https://www.ncbi.nlm.nih.gov/pubmed/35583868
http://dx.doi.org/10.1001/jamanetworkopen.2022.12702

Ejemplares similares